The Trump administration has announced an additional $250 million in aid to the Philippines, aimed at combating tuberculosis, improving maternal health, and addressing emerging disease threats. U.S. Secretary of State Marco Rubio revealed the funding on Thursday, highlighting the initiative as part of President Donald Trump’s new foreign aid strategy.
This announcement follows the $63 million commitment made during Trump’s meeting with Philippine President Ferdinand Marcos Jr. at the White House in July. Rubio emphasized that the aid reflects the “comprehensive bond between the United States and the Philippines” and showcases a more “efficient, time-limited, and narrowly targeted” America First approach to foreign assistance.
The Philippine embassy in Washington expressed appreciation for the aid but offered no further comments. The pledge underscores Washington’s continued strategic interest in strengthening bilateral ties with Manila while shifting away from traditional aid models such as USAID.
The Trump administration has consistently sought to reduce foreign assistance, attempting to withhold billions of dollars allocated by Congress as part of its broader “America First” policy. Despite these efforts, lawmakers, led by Republicans, have set aside billions in foreign aid funding, including $11 billion that must be allocated before the September 30 deadline.
After facing lawsuits, the administration agreed to release $6.5 billion in aid but continues to fight in court to block another $4 billion. The dispute is currently under review by the U.S. Supreme Court.
The latest pledge to the Philippines highlights Trump’s direct aid strategy, which prioritizes targeted investments in key areas while scaling back traditional multilateral pipelines. As Washington redefines its foreign assistance framework, the Philippines emerges as a key partner in regional health and security cooperation.


Venezuela Earthquake Health Risks Rise as Disease Monitoring Intensifies
US Investigates Deadly Strike on Iranian Wedding
AstraZeneca Halts Phase III Volrustomig Lung Cancer Trial After Efficacy Setback
Iran Vows Tougher Response as U.S. Sanctions Squeeze Economy
Hims & Hers Shares Fall as GLP-1 Costs Widen Q2 Loss
Alcohol is one of the most dangerous drugs, yet its presence is ubiquitous in social settings and celebrations
US-Backed Pediatric HIV Treatment Drops After Foreign Aid Changes, Study Finds
Hanmi Pharm Soars 30% on $2.3 Billion Genentech Obesity Drug Deal
Netanyahu Orders West Bank Settler Outposts Dismantled
Russia Eyes Putin-Trump-Xi Trilateral Meeting at China APEC Summit
Iran’s Hormuz Oil Pressure Fades as Gulf Crude Flows Continue
3 clinical-grade skincare creams you really shouldn’t buy online
Eli Lilly Eyes AtaiBeckley Acquisition to Expand Psychedelic Mental Health Pipeline
Lavrov Accuses Germany of ‘Declaring War’ on Russia
FDA Investigates New Cyclospora Outbreak as U.S. Cases Continue to Rise 



